Literature DB >> 17109410

Three-dimensional growth behavior of osteoblasts on biomimetic hydroxylapatite scaffolds.

M Rumpler1, A Woesz, F Varga, I Manjubala, K Klaushofer, P Fratzl.   

Abstract

The authors used rapid prototyping to produce three-dimensional hydroxylapatite scaffolds with controlled, fully interconnected porosity. The purpose of this study was to illuminate the effect of hormones on the osteogenic differentiation and to investigate how osteoblasts colonize the three-dimensional scaffold focusing on the formation of the cellular network. Preosteoblasts were seeded onto scaffolds, were optionally treated with the osteogenic hormones triiodo-L-thyronine (T3) and 1,25-dihydroxyvitamin-D3 (D3), and the expression of osteoblastic marker genes was investigated. Confocal laser scanning microscopy was used to investigate the three-dimensional growth behavior. Culturing cells on scaffolds strongly increased the expression of osteocalcin, osteoprotegerin, Runx2, and receptor activator of NFkB-ligand (RANKL). Treatment with T3 increased the expression of osteocalcin but did not change that of osteoprotegerin and Runx2. Treatment with D3 inhibited the expression of osteocalcin, Runx2, and osteoprotegerin. Both hormones had similar effects in the three-dimensional system as found in two-dimensional cultures although more accentuated, indicating that preosteoblasts behave more naturally on three-dimensional structures. The osteoblasts colonized the three-dimensional squared pores of scaffolds by forming a cellular network with a round central channel keeping it into the depth and depositing collagen fibrils. These results provide insight how osteoblasts colonize a three-dimensional system and underline the importance of this environment in osteoblastic differentiation studies. (c) 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17109410     DOI: 10.1002/jbm.a.30940

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  7 in total

1.  Indirect rapid prototyping of biphasic calcium phosphate scaffolds as bone substitutes: influence of phase composition, macroporosity and pore geometry on mechanical properties.

Authors:  M Schumacher; U Deisinger; R Detsch; G Ziegler
Journal:  J Mater Sci Mater Med       Date:  2010-10-15       Impact factor: 3.896

2.  Microcracks and osteoclast resorption activity in vitro.

Authors:  Monika Rumpler; Tanja Würger; Paul Roschger; Elisabeth Zwettler; Herwig Peterlik; Peter Fratzl; Klaus Klaushofer
Journal:  Calcif Tissue Int       Date:  2012-01-24       Impact factor: 4.333

3.  Enhanced osteoblastogenesis in three-dimensional collagen gels.

Authors:  Brya G Matthews; Dorit Naot; Karen E Callon; David S Musson; Rachel Locklin; Philippa A Hulley; Andrew Grey; Jillian Cornish
Journal:  Bonekey Rep       Date:  2014-08-06

4.  Physical properties and cellular responses to crosslinkable poly(propylene fumarate)/hydroxyapatite nanocomposites.

Authors:  Kee-Won Lee; Shanfeng Wang; Michael J Yaszemski; Lichun Lu
Journal:  Biomaterials       Date:  2008-04-09       Impact factor: 12.479

5.  The roles of matrix polymer crystallinity and hydroxyapatite nanoparticles in modulating material properties of photo-crosslinked composites and bone marrow stromal cell responses.

Authors:  Shanfeng Wang; Diederik H R Kempen; Michael J Yaszemski; Lichun Lu
Journal:  Biomaterials       Date:  2009-03-31       Impact factor: 12.479

6.  Osteogenic differentiation of human periosteal-derived cells in a three-dimensional collagen scaffold.

Authors:  Young-Mo Ryu; Young-Sool Hah; Bong-Wook Park; Deok Ryong Kim; Gu Seob Roh; Jong-Ryoul Kim; Uk-Kyu Kim; Gyu-Jin Rho; Geun-Ho Maeng; June-Ho Byun
Journal:  Mol Biol Rep       Date:  2010-01-28       Impact factor: 2.316

7.  The effect of geometry on three-dimensional tissue growth.

Authors:  Monika Rumpler; Alexander Woesz; John W C Dunlop; Joost T van Dongen; Peter Fratzl
Journal:  J R Soc Interface       Date:  2008-10-06       Impact factor: 4.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.